Connect with us

Cannabis News

New Jersey Lawmakers Approve Bill To Legalize Psilocybin Therapy

Published

on

New Jersey lawmakers have advanced a bill provide adults with regulated therapeutic access to psilocybin with appropriate health conditions, with the intention of continuing to work to enact it in the 2026 legislative session.

More than a year after the House Health Committee first took up and amended the legislation — sponsored by Reps. Herb Conaway (D), Clinton Calabrese (D) and Anthony Verrelli (D) — the panel met Monday, taking testimony and benefiting from it.

“We’re all broke in one way, shape or form,” Verrelli (D), one of the bill’s sponsors, said at Monday’s hearing. “This bill gives people another chance to heal and improve. And if they get better, it gives them an opportunity to improve their communities, their families and their lives in general, to break that cycle of trauma, whatever it looks like.”

The committee amended the legislation last year to match the Senate version. To the disappointment of the defenders, however, this meant removing provisions that would have more broadly legalized psilocybin for adult use.

The plan, which included the personal legislative provisions that were originally introduced in the same form as the one proposed by lawmakers in the 2024 session, has recently been released in amended versions. Those ingredients would make it legal for adults to “possess, possess, use, ingest, inhale, process, transport, deliver without consideration, or distribute without consideration” four grams or less of psilocybin.

The amended measures, however, would significantly expand legislation introduced in late 2020 to reduce penalties for possessing an ounce of psilocybin. That reform Governor Phil Murphy (D) signed it into law in 2021

Stacy Swanson, who testified on behalf of Veterans Exploring Treatment Solutions (VETS), emphasized at Monday’s hearing that “the invisible wounds of war don’t just affect the veteran, they affect the entire family.”

“This bill does not legalize recreational drugs,” he said. “It creates structured access that is clinically supervised, with the necessary integration and monitoring.”

In its modified version, The invoice It would charge the Department of Health (DOH) with regulating and licensing the manufacture, testing, transportation, delivery, sale and purchase of psilocybin. There would be five types of licenses: manufacturer, service center operator, testing lab, facilitator, and psilocybin worker.

The Psilocybin Advisory Committee would establish appropriate medical conditions for use, propose guidelines for psilocybin services and dosage, craft safety studies and informed consent practices, and oversee the education, training, and conduct of facilitators.

The stated goal would be to develop a long-term strategic plan for safe, accessible, and affordable access to psilocybin for those 21 and older.

Toward this end, a social equity program would include implementing grants to help low-income people cover the costs of psilocybin services. DOH would direct the implementation of programs for technical assistance, fee reduction and other support services.

Jesse McLaughlin, state advocacy director for Reason for Hope, said Monday hearing that psychedelic medicine represents “the next big step forward in psychiatry” and we need to prepare our healthcare system for it.

“Psilocybin therapy is time-intensive, labor-intensive and different from the way psychiatric care is delivered today,” he said.

To access psilocybin services under the bill, a patient with a qualifying condition would have to obtain a referral from a licensed health care professional. Services would also include mandatory preparation and integration sessions before and after psilocybin administration.

The Assembly bill is in the hands of the Appropriations Committee. The Friend the Senate has already cleared two panels in that chamber—Health, Human Services and Elderly Committee and Budget and Credit Committee.

A survey of New Jersey residents released last year bears this out A majority of state residents agree with making psilocybin available for therapeutic usealthough they were not specifically asked about the specific legislation.

The poll, by Stockton University’s William J. Hughes Center for Public Policy, found that 55 percent of respondents supported legalizing psilocybin for medical use under the supervision of a physician. Only 20% of respondents were against, and 24% were not sure. A percentage of respondents refused to answer the question.


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

In other New Jersey drug policy news, Voters earlier this month chose U.S. Rep. Mikie Sherrill (D-NJ) to be the state’s next governor.and now there’s a clearer path to the marijuana reform that consumers and advocates in the Garden State have long awaited: the option to grow it at home.

Meanwhile, as New Jersey’s first marijuana lounges opened this summerregulators shared information on where to find the sites and offered advice on the responsible use of cannabis in licensed businesses, including rock culture classics like “puff, puff, pass.”

New Jersey officials have also completed the curriculum for a no-cost marijuana training academy to help entrepreneurs interested in entering the cannabis industry.

Separately, in May, New Jersey Senate President Nick Scutari (D) introduced a bill that would recriminalize the purchase of marijuana from unlicensed sources-A last ditch effort to combat the illegal market and direct adults to licensed dealers.

In March, a former New Jersey Senate leader unsuccessfully ran for this year’s Democratic nomination for governor. “It’s time” to allow medical marijuana patients to grow their own cannabis plants for personal use. He also pledged to expand amnesty for people affected by the criminalization of marijuana, if elected, and supported the establishment of cannabis consumption halls.

The comments by Sweeney, the longest-serving Senate president in the state’s history, diverge from what the current governor has repeatedly said about home growing, arguing that the state’s adult marijuana market needs to mature more before allowing home growing.

That claim appears to be contradicted by dozens of small marijuana businesses and advocacy groups in New Jersey recently He asked Parliament to allow adults to grow their own cannabis.

user photo CostaPPR.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Cannabis News

Innovative substrate strategies boost plant production while reducing peat use

Published

on

By

Three recent studies from Dr. Jeb S. Fields’ Environmental Nursery Production Lab show that growers can reduce peat use in plant production by layering different substrate materials—a practice called substrate stratification—while maintaining plant growth or quality.

In the first study, the researchers tested how incorporating wood fiber into the bottom layers of containers affects plant growth. They found that using coarse wood fiber underneath and a finer moisture-retaining material on top helped the roots develop well, keeping the seedlings healthy and vigorous. The approach also offers growers the flexibility to tailor substrate mixes to specific crops or growing conditions.

A supporting study confirmed that layering low-peat and high-peat materials in the same container can significantly reduce overall peat use. Plants grown in these stratified mixtures performed as well or better than those grown in traditional uniform substrates.

A third study reinforces these findings, showing that stratified systems can cut total peat use while maintaining or improving plant quality compared to traditional uniform mixes.

Together, these findings give growers practical tools to reduce peat use, manage costs and achieve more sustainable production, all while maintaining the high-quality plants that customers expect.

Collectively, these findings provide practical strategies for nurseries and nurseries seeking to sustainably produce high-quality plants. By combining layered substrates, careful packaging and peat alternatives, growers can reduce peat dependence, improve root architecture and improve production efficiency.

These studies represent a step forward in sustainable gardening, demonstrating that environmentally responsible substrate management can go hand in hand with the production of high yielding plants.

According to Dr. Fields, “Researchers around the world have been looking for alternatives to peat for decades, but the answer may lie in managing the way we use the substrate we have. Through stratification, we can effectively reduce peat use by 50% without sacrificing plant growth or quality. Substrate stratification also allows the use of low-cost or recycled materials in place of permanent media and other sustainable growth materials and sustainable growth. Horticulture industry”.

The full article can be read on the ASHS HortTech e-journal website https://doi.org/10.21273/HORTTECH05570-24; https://doi.org/10.21273/HORTTECH05660-25; and https://doi.org/10.21273/HORTTECH05683-25

For more information:
American Society for Horticultural Science (ASHS)
ashlars.org

Continue Reading

Cannabis News

Striving for inclusivity in Caribbean cannabis market

Published

on

By











The government of Antigua and Barbuda has reiterated its intention to build a medical cannabis sector based on local empowerment, careful regulation and cultural respect. At a stakeholder dialogue organized by the Medicinal Cannabis Authority (MCA), officials presented a new roadmap for the development of medicinal cannabis on the island.

Addressing industry stakeholders, Attorney General Sir Steadroy Benjamin emphasized that the administration’s aim was to redirect the profits of this industry to people who have historically been shunned by foreign investors.

“I want to make it clear that my government (…) is fully committed to ensure that the economic benefits of this industry benefit the people of Antigua and Barbuda as a whole, and not just land investors,” he said, and to assure participants “that the pie is significant.”

This change comes as the authorities have acknowledged that previous economic initiatives in the country often concentrated profits in the hands of large operators. The government now wants to ensure that this trend is “ended”, with the new cannabis regulatory framework serving as a corrective model.

Read more at News Weed










Continue Reading

Cannabis News

Only Six Percent Of Marijuana Consumers Approve Of Trump’s Reform Actions, But Most Would Shift Opinion If He Reschedules, Poll Finds

Published

on

By

Only six percent of marijuana users approve of the Trump administration’s actions on cannabis policy so far, according to a new poll. Rumors abound that the president plans to direct federal rescheduling of cannabis.

The latest version of NuggMD and Marijuana Moment’s quarterly presidential approval tracking poll also found that 51 percent of respondents would support the current administration if marijuana were rescheduled or legalized.

Some President Donald Trump calls cannabis III. Despite the recent news that plans to reclassify the drug as Schedule I under the Controlled Substances Act are very positive, marijuana users’ support for the president’s marijuana “actions” declined in the last quarter.

1.6 percent of respondents said they “strongly approve” of the actions, 4.5 percent approve, a plurality of 38.4 percent are neutral, 26.1 percent disapprove and 29.5 percent strongly disapprove.

“Do you approve or disapprove of the presidential administration’s actions regarding cannabis?”
n: %
Strongly accept 7 1.6%
accept 20 4.5%
No opinion/Neutral 172 38.4%
Condemn 117 26.1%
Very disapproving 132 29.5%
448
Score (-50 to +50) -19,364
Clear Accept/Reject: -49.6%

However, the poll data also reinforced the idea that Trump could move the needle among cannabis-using voters by enacting key reforms, such as rescheduling or legalization.

It found that among respondents, 51 percent said they would change their level of support for the president if he took action on these reform proposals.

1.5 percent said they would support it less, while 47.5 percent said their opinion would not change.

“If the Trump administration were to reschedule or legalize cannabis, would that change your level of support?”
n: %
I would accept much more 172 38.4%
I could tolerate a bit more 56 12.5%
No change 213 47.5%
I would accept less 2 0.4%
I would accept much less 5 1.1%
448
Score (-50 to +50): 21,652
Clear Accept/Reject: 49.3%

“I find these data to be evidence that the White House needs to take tangible action on cannabis reprogramming to capture the clear political benefit of the public we poll, cannabis consumers who participate in state legal and regulated markets,” said Andrew Graham, chief communications officer for Nugg MD, Marijuana Moment.

“The trial balloon about the imminence of the overhaul is not going to cut it,” he said, adding that he doesn’t believe an executive leading the move to Schedule III “resolves the many problems with how federal law treats cannabis, a legal substance in many states.”

However, “I think it would benefit the industry and increase access, and consumers of cannabis would notice,” Graham said.

The latest quarterly poll found Trump’s overall approval rating among marijuana users down, from 11 percent in the previous quarter to around six percent this quarter.

The survey — which interviewed 448 cannabis users living in states with legal markets and has a margin of error of ±4.63 percentage points — was conducted before the president announced plans to move forward with the reorganization process initiated by the Biden administration, with deadlines for action ranging from Monday to early next year.

Trump confirmed Monday when asked by a reporter “very strongly” considering rescheduling cannabisHe said the reform “brings in enormous amounts of research that can’t be done if you don’t reclassify.”

Amid rumors of a reconsideration, top Democrats in Congress have complained that the reform would not go far enough, including Sen. Ron Wyden (D-OR) who called the move only a tentative one. president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval rating.

Meanwhile, it is an important organization in the drug testing industry Amid ‘sounding the alarm’ reports Trump may soon end marijuana reregulation proposalthat the reform would have “catastrophic consequences for the safety of US workers and the transportation sector.”

Cannabis industry players are hopeful that reform will be passed as soon as possible, but opponents — including the National Drug and Alcohol Screening Association (NDASA) and Smart Approaches to Marijuana (SAM) — are working to dissuade the administration before a final decision is made. For what it’s worth, a White House spokesperson told Marihuana Moment that no action has been taken so far.

They have been bipartisan members of Congress weighing a possible decision to reorganize last week—Democrats like Rep. Alex Ocasio-Cortez (D-NY) call the reform a “no” and others like Rep. Andy Harris (R-MD) have pushed back against the proposal.

Trump said this in mid-August he would make the reorganization decision in a week. But despite that timeline and increasing rumors, a White House spokesman told Marijuana Moment last week that “no final decision has been made on rescheduling marijuana.”

The Washington Post reported Thursday afternoon that Trump planned to issue an executive order to federal agencies to move ahead with cannabis rescheduling.

The outlet also said the president met with marijuana industry executives Robert F. Kennedy Jr. earlier this week in the Oval Office. with Secretary of Health and Human Services and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump called Johnson, the House Speaker, who opposed the rescheduling of cannabis,

If the administration ultimately enacts the rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition half a century ago, when it was banned under Article III. With a reclassification, marijuana has medical value and a lower abuse potential compared to Schedule I drugs like heroin.


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

Trump endorsed the rescheduling — as well as an initiative to legalize access to industrial banking and adult use in Florida — on the campaign trail. The president had been silent on the issue since taking office for a second term, until a meeting in August where, in response to a reporter’s question, he announced that the administration would decide to reschedule in a few weeks.

The possibility of an immediate rescheduling announcement comes a few weeks later the president signed a major spending bill that would effectively ban most consumer hemp productsdrawing criticism from hemp industry players who say the policy change would wipe out the market.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media